Author: Rebecca Shover
Black Women With SLE Have More Severe Disease & Poorer Outcomes
Feb 1, 2023
In Black women with SLE, symptom and treatment self-efficacy were inversely related to fatigue and...
Read MoreTips for Avoiding Medical Claim Denials & Getting Paid
Jan 31, 2023
Adhering to billing guidelines can be a frustrating and challenging task. Despite painstakingly...
Read MoreComplete Treatment Response Benefits Patients With CSU
Jan 27, 2023
For patients with chronic spontaneous urticaria (CSU), disease management is strongly associated...
Read MoreOPERA Trial Opts for Non-Surgical Treatment for Rectal Cancer
Jan 27, 2023
The 38-month follow-up data of the phase 3 OPERA trial showed that non-surgical treatment is...
Read MoreEven With Delay, Surgery Improves Survival in Early NSCLC Versus Stereotactic Radiation
Jan 27, 2023
Surgery was superior to stereotactic radiation for early non-small cell lung cancer, even in the...
Read MoreFucoidan May Improve QOL in Patients With Rectal Cancer
Jan 27, 2023
A randomized trial investigating fucoidan in patients with locally advanced rectal cancer (LARC)...
Read MoreIMbrave 151 Missed Primary Endpoint in Advanced BTC
Jan 27, 2023
Adding bevacizumab to atezolizumab plus cisplatin and gemcitabine did not significantly improve...
Read MoreNovel Fc-enhanced CTLA-4 Inhibitor Scores in Colorectal Cancer
Jan 27, 2023
The combination therapy of botensilimab plus balstilimab resulted in encouraging anti-tumor...
Read MoreNew Standard of Care for Colorectal Cancer
Jan 27, 2023
The phase 3 SUNLIGHT trial demonstrated that bevacizumab plus trifluridine/tipiracil (FTD/TPI)...
Read MoreSWOG 1815, First-Ever Phase 3 Trial in BTC, Fails
Jan 27, 2023
The triplet regimen of nab-paclitaxel plus gemcitabine plus cisplatin (GCN) did not improve the...
Read MoreSorafenib Plus TACE May Control HCC After Resection
Jan 27, 2023
The postoperative adjuvant combination therapy of sorafenib plus transarterial chemoembolization...
Read MoreNanvuranlat Prolongs PFS in Refractory Advanced BTC
Jan 27, 2023
Patients with pre-treated, advanced biliary tract cancer (BTC) may benefit from treatment with...
Read MoreNew First-Line Option for Metastatic Pancreatic Duct Cancer
Jan 27, 2023
The phase 3 NAPOLI-3 trial showed that liposomal irinotecan plus 5-fluorouracil/leucovorin and...
Read MoreZolbetuximab Plus mFOLFOX6 Scores in Gastric Cancer
Jan 27, 2023
Zolbetuximab added to mFOLFOX6 improved the progression-free survival (PFS) and overall survival...
Read MoreIdentify Actionable & Achievable Dietary Goals With 9 Questions
Jan 27, 2023
High-quality nutrition and diet are important factors when managing patients with or at risk for...
Read MoreContemporary Pharmacotherapy for NTM Infections
Jan 25, 2023
Pharmacotherapy for NTM disease often involves antimycobacterials in combination with bronchial...
Read MoreBicycling To Lose Weight
Jan 25, 2023
“Bicycling is a great way to lose weight. Swallowing bugs for an hour will spoil your...
Read MoreThe Criminalization of Medical Error Is Damaging to Both Physicians & Patients
Jan 24, 2023
Unfortunately, physicians run a high risk for encountering medical error at some point within...
Read More